179
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma

, , , , , , , , & show all
Pages 357-367 | Received 12 Oct 2022, Accepted 16 Feb 2023, Published online: 02 Mar 2023